BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1388842)

  • 21. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies.
    Planz O; Seiler P; Hengartner H; Zinkernagel RM
    Nature; 2003 Nov; 426(6965):474. PubMed ID: 14647387
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibroblasts as efficient antigen-presenting cells in lymphoid organs.
    Kündig TM; Bachmann MF; DiPaolo C; Simard JJ; Battegay M; Lother H; Gessner A; Kühlcke K; Ohashi PS; Hengartner H
    Science; 1995 Jun; 268(5215):1343-7. PubMed ID: 7761853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological tolerance to a non-cytopathic virus is not inheritable in mice.
    Stitz L; Zinkernagel RM
    Immunology; 1984 Jun; 52(2):205-9. PubMed ID: 6203830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A suspenseful game of 'hide and seek' between virus and host.
    Oldstone MB
    Nat Immunol; 2007 Apr; 8(4):325-7. PubMed ID: 17375090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells.
    Battegay M; Kyburz D; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology.
    Battegay M; Seiler P; Hunziker L; Wolf K; Zinkernagel RM
    J Infect Dis; 2001 May; 183(9):1425-7. PubMed ID: 11294679
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactivity and tolerance of virus-specific T cells.
    Zinkernagel RM; Pircher HP; Schulz M; Leist T; Oehen S; Hengartner H
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():843-51. PubMed ID: 2701218
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunology. Tolerance by exhaustion.
    von Boehmer H
    Nature; 1993 Apr; 362(6422):696. PubMed ID: 8469279
    [No Abstract]   [Full Text] [Related]  

  • 29. Abrogation of tolerance to a chronic viral infection.
    Jamieson BD; Somasundaram T; Ahmed R
    J Immunol; 1991 Nov; 147(10):3521-9. PubMed ID: 1940352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response of the mouse to lymphocytic choriomeningitis virus. III. Differences of numbers of cytotoxic T lymphocytes in spleens of mice of different strains.
    Moskophidis D; Lehmann-Grube F
    Cell Immunol; 1983 Apr; 77(2):279-89. PubMed ID: 6601994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune response of the mouse to lymphocytic choriomeningitis virus. II. Active suppression of cell-mediated immunity by infection with high virus doses.
    Lehmann-Grube F; Cihak J; Varho M; Tijerina R
    J Gen Virol; 1982 Feb; 58(Pt 2):223-35. PubMed ID: 6460847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The art of tolerance.
    Starzl TE
    Nat Med; 1998 Sep; 4(9):1006-8. PubMed ID: 9734388
    [No Abstract]   [Full Text] [Related]  

  • 36. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
    Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
    Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immune system in AIDS.
    Laurence J
    Sci Am; 1985 Dec; 253(6):84-93. PubMed ID: 2999972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.
    Zarozinski CC; McNally JM; Lohman BL; Daniels KA; Welsh RM
    J Virol; 2000 Apr; 74(8):3650-8. PubMed ID: 10729141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis.
    Oldstone MB; Ahmed R; Byrne J; Buchmeier MJ; Riviere Y; Southern P
    Br Med Bull; 1985 Jan; 41(1):70-4. PubMed ID: 3882190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.